AGE is a black box. I don't think hardly anyone knows what's really going on there, except for its inner circle. That said, if you add up the shares of Juvenescence, Broadwood Capital, Biotime, company insiders and recent option executors, it accounts for about 80% of shares held. So its inner circle is about as large as you will find. As for the 50% share price drop in May, and the 50% share price increase in June, I would say traders used the disappointment of the reduced programs mentioned in the 1Q19 quarterly report to send the stock down, and then traded it back up knowing all the 1Q19 quarterly report really did was tell us AGE is going to be even more mysterious than it already was. AGE looks like either a zero or hero to me. Either management's silence is because nothing is going on, or because there is a lot going on that they don't want to share with others. Personally, I don't think Mike West, Jim Mellon and Greg Bailey all threw in their lot (and $50mm) with AgeX to have it fall apart in the first year. Also notice they haven't had a single share offering since going public in late 2018, and they haven't hyped a single thing about the company: no big press releases, no videos, no conference call.....just a nearly information-less quarterly report. What would you rather see? Mike West, Aubrey de Grey and Russell Skibsted making the rounds, pitching the company and raising money through share offerings? Or a company keeping its head down and efforts secret?
